On Friday, Lilly(Eli) & Co (NYSE: LLY) opened lower -1.30% from the last session, before settling in for the closing price of $829.74. Price fluctuations for LLY have ranged from $551.26 to $972.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 9.91%. Company’s average yearly earnings per share was noted 109.72% at the time writing. With a float of $850.72 million, this company’s outstanding shares have now reached $949.38 million.
The extent of productivity of a business whose workforce counts for 43000 workers is very important to gauge. In terms of profitability, gross margin is 81.56%, operating margin of 35.33%, and the pretax margin is 24.84%.
Lilly(Eli) & Co (LLY) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Lilly(Eli) & Co is 10.39%, while institutional ownership is 73.30%. The most recent insider transaction that took place on Sep 03 ’24, was worth 23,281,840. In this transaction 10% Owner of this company sold 24,084 shares at a rate of $966.69, taking the stock ownership to the 96,891,978 shares. Before that another transaction happened on Aug 27 ’24, when Company’s 10% Owner sold 24,552 for $968.46, making the entire transaction worth $23,777,668. This insider now owns 96,916,062 shares in total.
Lilly(Eli) & Co (LLY) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 109.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.80% during the next five years compared to 13.74% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Check out the current performance indicators for Lilly(Eli) & Co (LLY). In the past quarter, the stock posted a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.78. Likewise, its price to free cash flow for the trailing twelve months is 548.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 9.14, a number that is poised to hit 5.46 in the next quarter and is forecasted to reach 22.61 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
The latest stats from [Lilly(Eli) & Co, LLY] show that its last 5-days average volume of 7.08 million was superior to 3.06 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 42.30%. Additionally, its Average True Range was 24.17.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 31.73%, which indicates a significant increase from 30.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.75% in the past 14 days, which was lower than the 32.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $910.81, while its 200-day Moving Average is $826.85. Now, the first resistance to watch is $829.04. This is followed by the second major resistance level at $839.16. The third major resistance level sits at $845.31. If the price goes on to break the first support level at $812.77, it is likely to go to the next support level at $806.62. The third support level lies at $796.50 if the price breaches the second support level.
Lilly(Eli) & Co (NYSE: LLY) Key Stats
There are currently 949,316K shares outstanding in the company with a market cap of 767.29 billion. Presently, the company’s annual sales total 34,124 M according to its annual income of 5,240 M. Last quarter, the company’s sales amounted to 11,303 M and its income totaled 2,967 M.
